Asia Pacific Stomach Cancer Treatment Market Size & Outlook
Asia Pacific stomach cancer treatment market, 2018-2028 (US$M)
Related Markets
Asia Pacific stomach cancer treatment market highlights
- The Asia Pacific stomach cancer treatment market generated a revenue of USD 1,988.3 million in 2020.
- The market is expected to grow at a CAGR of 11.2% from 2021 to 2028.
- In terms of segment, standard chemotherapy was the largest revenue generating treatment type in 2020.
- Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- Country-wise, South Korea is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 1,988.3 million |
| Market revenue in 2028 | USD 4,633.5 million |
| Growth rate | 11.2% (CAGR from 2020 to 2028) |
| Largest segment | Standard chemotherapy |
| Fastest growing segment | Immunotherapy |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standard Chemotherapy, Targeted Therapy, Immunotherapy |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 56.8% of the global stomach cancer treatment market in 2020.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2028.
- Europe is the fastest growing regional market and is projected to reach USD 1,990.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stomach Cancer Treatment Market Scope
Stomach Cancer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific stomach cancer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.
Standard chemotherapy was the largest segment with a revenue share of 52.22% in 2020. Horizon Databook has segmented the Asia Pacific stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2028.
Reasons to subscribe to Asia Pacific stomach cancer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific stomach cancer treatment market databook
-
Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific stomach cancer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific stomach cancer treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific stomach cancer treatment market size, by country, 2018-2028 (US$M)
Asia Pacific Stomach Cancer Treatment Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
